OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	205
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	88
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	71
Neonatal ocular prophylaxis in the United States: is it still necessary?	62
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	61
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	60
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	60
Challenges in preserving antibiotic effectiveness: time for a novel approach	49
Visceral leishmaniasis elimination in India: progress and the road ahead	46
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	42
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	41
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	39
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	38
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	37
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	33
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	33
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	31
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients	30
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	29
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	27

Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China